Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia.
Grembecka J, He S, Shi A, Purohit T, Muntean AG, Sorenson RJ, Showalter HD, Murai MJ, Belcher AM, Hartley T, Hess JL, Cierpicki T.
Grembecka J, et al. Among authors: cierpicki t.
Nat Chem Biol. 2012 Jan 29;8(3):277-84. doi: 10.1038/nchembio.773.
Nat Chem Biol. 2012.
PMID: 22286128
Free PMC article.